Insider Trading activities at Haemonetics Corp (HAE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp (HAE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 313143.

Total stock buying since 2014: $2,423,480.
Total stock sales since 2014: $117,261,539.
Total stock option exercises since 2014: $45,452,203.

1 2

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Haemonetics Corp* (*HAE*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2024	0	$0	38,339	$3,463,122	109,167	$4,617,635
2023	0	$0	22,518	$1,982,726	208,567	$6,304,686
2022	0	$0	347,292	$26,657,770	265,710	$12,102,291
2021	0	$0	73,005	$6,256,396	57,986	$2,210,283
2020	4,000	$323,720	144,116	$13,112,950	14,474	$604,744
2019	0	$0	292,546	$33,522,423	71,638	$2,947,916
2018	0	$0	115,174	$12,058,890	74,939	$2,804,531
2017	0	$0	143,148	$6,548,301	136,879	$4,682,353
2016	60,000	$2,099,760	25,056	$912,447	20,338	$583,166
2015	0	$0	208,434	$8,620,345	205,637	$5,689,540
2014	0	$0	118,607	$4,126,169	115,927	$2,905,058

Table 2. Monthly summary of insider trading at *Haemonetics Corp* (*HAE*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2024-07	0	$0	6,527	$592,388	0	$0
2024-06	0	$0	0	$0	104,516	$4,352,046
2024-05	0	$0	31,812	$2,870,734	4,651	$265,589
2023-09	0	$0	12,748	$1,123,769	0	$0
2023-07	0	$0	4,928	$443,520	4,928	$281,314
2023-06	0	$0	2,538	$223,445	203,639	$6,023,372
2023-05	0	$0	2,304	$191,992	0	$0
2022-09	0	$0	315,842	$24,678,963	265,710	$12,102,291
2022-08	0	$0	8,016	$590,859	0	$0
2022-07	0	$0	42	$2,779	0	$0
2022-06	0	$0	1,944	$121,732	0	$0
2022-05	0	$0	21,259	$1,252,750	0	$0
2022-04	0	$0	189	$10,687	0	$0
2021-10	0	$0	195	$14,025	0	$0
2021-09	0	$0	100	$6,461	0	$0
2021-08	0	$0	22,667	$1,371,580	22,667	$859,645
2021-07	0	$0	4,293	$285,913	0	$0
2021-06	0	$0	5,039	$284,240	0	$0
2021-05	0	$0	14,845	$819,243	10,353	$367,562
2021-04	0	$0	170	$20,304	0	$0
2021-03	0	$0	492	$59,073	0	$0
2021-02	0	$0	25,204	$3,395,557	24,966	$983,076
2020-10	0	$0	1,442	$152,956	0	$0
2020-09	0	$0	101	$8,959	0	$0

Table 3. Detailed insider trading at *Haemonetics Corp* (*HAE*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2024-07-26	Strong Stewart W (President, Global Hospital)	Sale	4,312	91.15	393,038
2024-07-12	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	79	90.00	7,110
2024-07-11	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	2,136	90.00	192,240
2024-06-06	Simon, Christopher (President & CEO)	Option Ex	104,516	41.64	4,352,046
2024-05-29	Basil Michelle L (EVP and General Counsel)	Sale	12,990	88.22	1,145,912
2024-05-29	Strong Stewart W (President, Global Hospital)	Sale	8,857	87.53	775,253
2024-05-20	Llorens Josep (EVP, Global Manufacturing)	Sale	987	95.08	93,843
2024-05-20	Basil Michelle L (EVP and General Counsel)	Sale	1,604	95.08	152,508
2024-05-20	Strong Stewart W (President, Global Hospital)	Sale	686	95.11	65,245
2024-05-20	Strong Stewart W (President, Global Hospital)	Option Ex	2,241	56.57	126,773
2024-05-17	Llorens Josep (EVP, Global Manufacturing)	Sale	822	94.82	77,942
2024-05-17	Basil Michelle L (EVP and General Counsel)	Sale	1,073	95.00	101,935
2024-05-16	Llorens Josep (EVP, Global Manufacturing)	Sale	770	96.14	74,027
2024-05-16	Basil Michelle L (EVP and General Counsel)	Sale	985	96.14	94,697
2024-05-16	Strong Stewart W (President, Global Hospital)	Sale	733	96.04	70,397
2024-05-16	Strong Stewart W (President, Global Hospital)	Option Ex	2,410	57.60	138,816
2024-05-06	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	2,305	95.00	218,975
2023-09-12	Strong Stewart W (President, Global Hospital)	Sale	228	90.65	20,668
2023-09-11	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	2,305	90.00	207,450
2023-09-05	Dockendorff Charles J (Director)	Sale	10,215	87.68	895,651
2023-07-18	Llorens Josep (EVP, Global Manufacturing)	Sale	4,928	90.00	443,520
2023-07-18	Llorens Josep (EVP, Global Manufacturing)	Option Ex	4,928	57.09	281,314
2023-06-29	Simon, Christopher (President & CEO)	Option Ex	196,746	28.61	5,629,886
2023-06-07	Strong Stewart W (President, Global Hospital)	Sale	2,538	88.04	223,445
2023-06-07	Strong Stewart W (President, Global Hospital)	Option Ex	6,893	57.09	393,486
2023-05-30	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	2,304	83.33	191,992
2022-09-19	Miller Laurie A. (SVP, Human Resources)	Sale	212	76.25	16,165
2022-09-19	Basil Michelle L (EVP and General Counsel)	Sale	11,448	78.36	897,065
2022-09-19	Basil Michelle L (EVP and General Counsel)	Option Ex	8,688	45.55	395,712
2022-09-15	Basil Michelle L (EVP and General Counsel)	Sale	168,990	78.13	13,203,185
2022-09-15	Basil Michelle L (EVP and General Counsel)	Option Ex	142,790	45.55	6,503,655
2022-08-15	Kroll Mark W (Director)	Sale	8,016	73.71	590,859
2022-07-05	Miller Laurie A. (SVP, Human Resources)	Sale	42	66.18	2,779
2022-06-13	Miller Laurie A. (SVP, Human Resources)	Sale	30	62.60	1,878
2022-06-13	Goldstein Dan (VP, Corporate Controller)	Sale	42	62.60	2,629
2022-06-13	Basil Michelle L (EVP and General Counsel)	Sale	277	62.60	17,340
2022-06-13	Simon, Christopher (President & CEO)	Sale	1,148	62.60	71,864
2022-06-02	Miller Laurie A. (SVP, Human Resources)	Sale	198	62.69	12,412
2022-06-02	Goldstein Dan (VP, Corporate Controller)	Sale	249	62.69	15,609
2022-05-19	Miller Laurie A. (SVP, Human Resources)	Sale	182	59.10	10,756
2022-05-19	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	1,384	59.10	81,794
2022-05-19	Llorens Josep (EVP, Global Manufacturing)	Sale	2,836	59.10	167,606
2022-05-19	Goldstein Dan (VP, Corporate Controller)	Sale	134	59.10	7,919
2022-05-19	Basil Michelle L (EVP and General Counsel)	Sale	3,258	59.10	192,547
2022-05-19	Simon, Christopher (President & CEO)	Sale	4,992	59.10	295,026
2022-05-19	Strong Stewart W (President, Global Hospital)	Sale	2,168	59.10	128,128
2022-05-16	Miller Laurie A. (SVP, Human Resources)	Sale	31	56.10	1,739
2022-05-16	Llorens Josep (EVP, Global Manufacturing)	Sale	107	56.10	6,002
2022-05-16	Goldstein Dan (VP, Corporate Controller)	Sale	50	56.10	2,805
2022-05-16	Basil Michelle L (EVP and General Counsel)	Sale	196	56.10	10,995
2022-05-16	Simon, Christopher (President & CEO)	Sale	832	56.10	46,675
2022-04-18	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	189	56.55	10,687
2021-10-25	Basil Michelle L (EVP and General Counsel)	Sale	120	71.93	8,631
2021-10-25	Strong Stewart W (President, Global Hospital)	Sale	75	71.93	5,394
2021-09-07	Llorens Josep (EVP, Global Manufacturing)	Sale	100	64.61	6,461
2021-08-23	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	22,667	60.51	1,371,580
2021-08-23	Burke William P. Mr. (EVP, Chief Financial Officer)	Option Ex	22,667	37.92	859,645
2021-07-01	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	4,293	66.60	285,913
2021-06-14	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	190	59.87	11,375
2021-06-14	Simon, Christopher (President & CEO)	Sale	1,200	59.87	71,844
2021-06-07	Goldstein Dan (VP, Corporate Controller)	Sale	81	55.09	4,462
2021-06-07	Basil Michelle L (EVP and General Counsel)	Sale	442	55.09	24,349
2021-06-07	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	411	55.09	22,641
2021-06-07	Simon, Christopher (President & CEO)	Sale	2,715	55.09	149,569
2021-05-26	Kroll Mark W (Director)	Sale	11,813	55.10	650,896
2021-05-26	Kroll Mark W (Director)	Option Ex	10,353	35.50	367,562
2021-05-19	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	92	55.19	5,077
2021-05-19	Goldstein Dan (VP, Corporate Controller)	Sale	42	55.19	2,317
2021-05-19	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	112	55.19	6,181
2021-05-19	Basil Michelle L (EVP and General Counsel)	Sale	220	55.19	12,141
2021-05-19	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	238	55.19	13,135
2021-05-19	Simon, Christopher (President & CEO)	Sale	1,024	55.19	56,514
2021-05-17	Goldstein Dan (VP, Corporate Controller)	Sale	42	55.97	2,350
2021-05-17	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	102	55.97	5,708
2021-05-17	Basil Michelle L (EVP and General Counsel)	Sale	204	55.97	11,417
2021-05-17	Simon, Christopher (President & CEO)	Sale	956	55.97	53,507
2021-04-16	Lingamneni Anila (EVP, Chief Technology Officer)	Sale	170	119.44	20,304
2021-03-08	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	107	120.07	12,847
2021-03-08	Basil Michelle L (EVP and General Counsel)	Sale	385	120.07	46,226
2021-02-04	Goldstein Dan (VP, Corporate Controller)	Sale	2,671	135.93	363,055
2021-02-04	Goldstein Dan (VP, Corporate Controller)	Option Ex	2,433	75.25	183,088
2021-02-04	Dockendorff Charles J (Director)	Sale	12,180	134.53	1,638,575
2021-02-04	Dockendorff Charles J (Director)	Option Ex	12,180	35.50	432,426
2021-02-04	Meelia Richard J (Director)	Sale	10,353	134.64	1,393,927
2021-02-04	Meelia Richard J (Director)	Option Ex	10,353	35.50	367,562
2020-10-26	Goldstein Dan (VP, Corporate Controller)	Sale	100	106.00	10,600
2020-10-26	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	1,161	106.00	123,066
2020-10-23	Basil Michelle L (EVP and General Counsel)	Sale	181	106.58	19,290
2020-09-08	Llorens Josep (SVP, Global Manufacturing)	Sale	101	88.71	8,959
2020-08-11	Abernathy Robert E (Director)	Buy	4,000	80.93	323,720
2020-06-30	Simon, Christopher (President & CEO)	Sale	5,084	87.79	446,324
2020-06-16	Goldstein Dan (VP, Corporate Controller)	Sale	3,040	91.53	278,251
2020-06-16	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	6,869	91.53	628,719
2020-06-16	Basil Michelle L (EVP and General Counsel)	Sale	13,436	91.27	1,226,263
2020-06-16	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	12,614	91.28	1,151,368
2020-06-15	Goldstein Dan (VP, Corporate Controller)	Sale	1,374	87.44	120,135
2020-06-15	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	8,422	88.86	748,336
2020-06-15	Scanlan Jacqueline (SVP, Global Human Resources)	Option Ex	2,889	41.64	120,297
2020-06-15	Basil Michelle L (EVP and General Counsel)	Sale	10,578	87.71	927,796
2020-06-15	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	9,720	87.71	852,541
2020-06-15	Simon, Christopher (President & CEO)	Sale	45,723	87.71	4,010,364
2020-06-12	Goldstein Dan (VP, Corporate Controller)	Sale	42	82.29	3,456
2020-06-12	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	111	89.29	9,911
2020-06-12	Basil Michelle L (EVP and General Counsel)	Sale	203	89.29	18,125
2020-06-12	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	197	89.29	17,590
2020-06-12	Simon, Christopher (President & CEO)	Sale	1,294	89.29	115,541
2020-06-09	Goldstein Dan (VP, Corporate Controller)	Sale	187	97.19	18,174
2020-06-08	Goldstein Dan (VP, Corporate Controller)	Sale	1,189	98.06	116,593
2020-06-08	Goldstein Dan (VP, Corporate Controller)	Option Ex	1,106	41.64	46,053
2020-06-08	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	324	97.03	31,437
2020-06-08	Basil Michelle L (EVP and General Counsel)	Sale	687	97.03	66,659
2020-06-08	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	639	97.03	62,002
2020-06-08	Simon, Christopher (President & CEO)	Sale	2,920	97.03	283,327
2020-05-18	Goldstein Dan (VP, Corporate Controller)	Sale	101	101.72	10,273
2020-05-15	Llorens Josep (SVP, Global Manufacturing)	Sale	107	100.44	10,747
2020-05-15	Goldstein Dan (VP, Corporate Controller)	Sale	42	100.44	4,218
2020-05-15	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	110	100.44	11,048
2020-05-15	Basil Michelle L (EVP and General Counsel)	Sale	203	100.44	20,389
2020-05-15	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	221	100.44	22,197
2020-05-15	Simon, Christopher (President & CEO)	Sale	1,008	100.44	101,243
2020-04-09	Kroll Mark W (Director)	Sale	10,902	102.00	1,112,004
2020-04-09	Kroll Mark W (Director)	Option Ex	6,573	45.45	298,742
2020-04-08	Goldstein Dan (VP, Corporate Controller)	Sale	399	97.12	38,750
2020-04-07	Goldstein Dan (VP, Corporate Controller)	Sale	201	103.91	20,885
2020-04-06	Goldstein Dan (VP, Corporate Controller)	Sale	2,607	101.62	264,923
2020-04-06	Goldstein Dan (VP, Corporate Controller)	Option Ex	2,607	34.42	89,732
2020-03-10	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	207	99.63	20,623
2020-03-09	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	118	98.00	11,564
2020-03-09	Basil Michelle L (EVP and General Counsel)	Sale	395	98.00	38,710
2020-03-06	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	1,299	100.50	130,549
2020-03-06	Scanlan Jacqueline (SVP, Global Human Resources)	Option Ex	1,299	38.43	49,920
2019-11-11	Bolorforosh Said (EVP, Chief Technology Officer)	Sale	339	118.27	40,093
2019-11-11	Meelia Richard J (Director)	Sale	6,573	118.15	776,599
2019-11-11	Meelia Richard J (Director)	Option Ex	6,573	45.45	298,742
2019-11-11	Gelbman Ronald G (Director)	Sale	16,926	118.26	2,001,668
2019-11-11	Gelbman Ronald G (Director)	Option Ex	16,926	40.48	685,096
2019-10-29	Goldstein Dan (VP, Corporate Controller)	Sale	237	122.69	29,077
2019-10-29	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	1,448	122.69	177,655
2019-10-28	Goldstein Dan (VP, Corporate Controller)	Sale	100	120.33	12,033
2019-10-28	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	1,155	120.33	138,981
2019-10-25	Goldstein Dan (VP, Corporate Controller)	Sale	1,456	120.32	175,185
2019-10-25	Goldstein Dan (VP, Corporate Controller)	Option Ex	1,456	34.21	49,809
2019-10-25	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	11,231	120.26	1,350,640
2019-10-25	Burke William P. Mr. (EVP, Chief Financial Officer)	Option Ex	11,231	34.21	384,212
2019-10-09	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	2,909	123.52	359,310
2019-10-09	Basil Michelle L (EVP and General Counsel)	Sale	10,633	123.51	1,313,313
2019-10-09	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	22,704	123.64	2,807,122
2019-10-08	Scanlan Jacqueline (SVP, Global Human Resources)	Sale	2,295	122.34	280,770
2019-10-08	Basil Michelle L (EVP and General Counsel)	Sale	8,883	122.34	1,086,746
2019-10-08	Burke William P. Mr. (EVP, Chief Financial Officer)	Sale	18,950	122.34	2,318,343

1 2

Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month